Mode
Text Size
Log in / Sign up

Review of preclinical interventions for heat stroke pathophysiology and gapsHeat Stroke Harms Your Cells: New Clues Could Change Treatment

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that preclinical data on these compounds for heat stroke are preliminary and not validated for human use.

This is a narrative review that synthesizes preclinical evidence on potential interventions for heat stroke pathophysiology. The scope covers compounds including astragaloside IV, curcumin, melatonin, rapamycin, taurine, and acetyl-L-carnitine, focusing on mechanisms like mitochondrial dysfunction, glucose-lipid metabolic restructuring, impaired substrate utilization, energy depletion, intestine barrier disruption, endotoxemia, brain hypothalamic dysregulation, lung oxidative stress, and lung barrier leakage.

The authors argue that these interventions may target specific pathways in heat stroke, but they do not report pooled effect sizes or primary outcomes, as this is a qualitative synthesis. The main finding is that preclinical data suggest potential mechanisms of action, but efficacy and safety in humans are not established.

Key limitations noted include that most current evidence is derived from preclinical studies, human studies are still needed to confirm efficacy and safety, translational gaps remain with limited validation in heat stroke-specific models, there is a lack of biomarker-guided patient stratification, and insufficient data on vulnerable populations.

Practice relevance is restrained; the review highlights that these interventions are not validated for clinical use in heat stroke. The authors caution against overstatement of efficacy and safety in human heat stroke, emphasizing the need for further research.

What happens inside your cells during heat stroke

Think of your cells as tiny cities. Each one needs energy to function. That energy comes from small structures inside your cells called mitochondria. They are the power plants of your body.

When heat stroke hits, those power plants take a direct hit. The heat damages their structure. They stop making energy properly. Some of them even break apart.

This is where the real trouble begins.

Without working power plants, your cells cannot do their jobs. Your gut lining weakens. Your brain struggles to control your body temperature. Your lungs start leaking fluid. One problem leads to another, and soon multiple organs are failing.

The review calls this energy failure the "pivotal link" between getting hot and getting seriously sick. It is the middle step that doctors have been missing.

A new way of thinking about heat stroke

For years, the main goal was simple: cool the body down. And that is still critical. But this research suggests that cooling alone may not be enough.

Here is the twist. Even after the body temperature returns to normal, the mitochondrial damage can continue. The power plants stay broken. The energy crisis inside the cells keeps going.

This explains why some people who seem to recover from heat stroke still develop organ failure hours or even days later. The damage was already set in motion at the cellular level.

The review points to three main problems that happen inside the cells:

First, the mitochondria get physically damaged. Their inner membranes warp and tear. Second, they stop burning fuel efficiently. The body cannot use sugar or fat for energy the way it should. Third, the cells run out of energy completely.

Once that happens, organs start shutting down.

The review looked at dozens of studies on how heat stroke affects the body at the cellular level. The researchers focused on three organs that take the worst hit: the gut, the brain, and the lungs.

In the gut, energy failure causes the intestinal lining to become leaky. Bacteria from the digestive tract escape into the bloodstream. This triggers widespread inflammation throughout the body.

In the brain, the hypothalamus (the part that controls body temperature) stops working correctly. This creates a dangerous cycle where the body cannot regulate its own heat.

In the lungs, the cells that form the air sacs start breaking down. Fluid builds up. Breathing becomes harder.

This doesn't mean a new treatment is ready for your doctor's office.

The review also looked at potential treatments that could protect the mitochondria during heat stroke. Some are natural compounds like curcumin (found in turmeric) and astragaloside IV (from a traditional Chinese herb). Others are existing drugs like melatonin and rapamycin.

These substances appear to help in animal studies. They protect the mitochondria from damage. They help the cells clear out broken power plants and build new ones. They improve how the body uses fuel for energy.

But here is the honest truth. Almost all of this evidence comes from lab experiments and animal studies. None of these treatments have been tested in humans specifically for heat stroke.

What this means for you right now

If you or someone you love faces extreme heat, the basics still matter most. Get out of the heat. Cool the body down. Seek medical help for signs of heat stroke like confusion, passing out, or very high body temperature.

Do not try to treat heat stroke with supplements or herbs at home. That is not safe. These potential treatments are still being studied.

What this research does is give scientists a clearer target. Instead of just trying to cool the body, future treatments might aim to protect the mitochondria directly. This could mean giving a drug that stabilizes the power plants before they break. Or giving the body extra fuel that the damaged mitochondria can still use.

The limits of this research

This is a review of existing studies, not a new experiment. The authors are clear about the gaps. Most of the evidence comes from animal models. Human studies are still needed. There are no reliable blood tests yet to tell which patients have the worst mitochondrial damage. And older adults or people with chronic diseases may respond differently than healthy young people.

The review also does not tell us exactly when to give these potential treatments. Before heat exposure? Right after? Hours later? Those details matter a lot.

What happens next

The researchers call for several next steps. They want better ways to monitor energy metabolism in real time during heat stroke. They want early warning signs that can predict which patients will develop organ failure. And they want personalized treatments based on a person's age, health conditions, and metabolic type.

This kind of research takes time. Clinical trials must prove that any new treatment is safe and effective in humans. That process can take years.

But for the first time, scientists have a clear picture of what goes wrong inside the cells during heat stroke. And they have a list of compounds worth testing. That is real progress for a condition that has not seen a major treatment advance in decades.

For now, the best protection is prevention. Stay cool. Stay hydrated. And know the signs of heat stroke before they become an emergency.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Heat stroke (HS) is a life-threatening acute condition characterized by hyperthermia, central nervous system dysfunction, and multiple organ failure. Energy metabolism disruption serves as a pivotal link between hyperthermia and multi-organ injury. This review synthesizes current evidence on the mechanisms of energy metabolism dysregulation in HS and evaluates emerging intervention strategies. Mitochondrial dysfunction—manifested as structural damage, oxidative phosphorylation impairment, and excessive fission—represents an initiating event. This is followed by glucose-lipid metabolic restructuring, impaired substrate utilization, and energy depletion. These metabolic derangements mediate secondary injury in the intestine (barrier disruption and endotoxemia), brain (hypothalamic dysregulation), and lung (oxidative stress and barrier leakage). Intervention strategies are categorized into mitochondrial protection (e.g., astragaloside IV, curcumin), mitophagy modulation (e.g., melatonin, rapamycin), and substrate metabolism regulation (e.g., taurine, acetyl-L-carnitine). Notably, most current evidence for these interventions is derived from preclinical studies, and HS-validated human studies are still needed to confirm their efficacy and safety. While these approaches show promise in preclinical models, translational gaps remain, including limited validation in HS-specific models, lack of biomarker-guided patient stratification, and insufficient data on vulnerable populations. Future priorities include dynamic metabolic monitoring, identification of early-warning biomarkers, and development of personalized interventions tailored to age, comorbidity status, and metabolic phenotype.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.